This posting is triggered by a question, I was asked by a New THD resident during our meal time conversation just recently. I titled it, The Names We Do Not Hear- Who is David B Katague in FDA?
My FDA Fellow Scientists and Colleagues, Rockville, MD, 1990. From L to R: Ernie Pappas, M.S., Suva Roy, Ph.D and David B Katague, Ph.D (me)
And then there are names like David B. Katague.
A name that does not shout. A name that does not seek the spotlight. A name that, quietly and faithfully, does its work.
In the vast machinery of the U.S. Food and Drug Administration, where decisions ripple out to millions of lives, David B. Katague served not as a public figure, but as something perhaps more enduring, a scientist entrusted with responsibility. A first-line supervisor, not a public figure.
A Chemistry Team Leader in the Center for Drug Evaluation and Research.
It sounds clinical. Almost sterile. But behind those words lies a human story, one of discipline, precision, and a kind of silent guardianship.
I often think about the unseen hands that shape our lives.
When we take an antibiotic, when a treatment works as expected, when a medication does what it promises, we rarely pause to ask:
Who made sure this was safe? Not the executives. Not the politicians. But individuals like Katague.
People who read through pages of data most of us would never understand.
People who question, verify, challenge. People who sign their names not for recognition, but for accountability.
There is something deeply humbling about that signature.
A name written at the bottom of a document that says, in essence:
This is safe enough for the public.
Think about that for a moment. The weight of that decision. The quiet courage it takes.
The discipline to remain invisible in a world that often rewards visibility above all else.
As I reflect on my own journey, through years of public service, through moments that placed me close to history, through a life now measured more in reflection than ambition, I find myself drawn more and more to these quieter stories.
Because in the end, most of us will not be remembered for grand gestures.
We will be remembered, if at all, for the integrity of our work. For the way we showed up.
For the responsibilities we carried when no one was watching.
The Katague name, as I’ve come to understand it, stretches across continents from the provinces of the Philippines to communities in America, Australia, and New Zealand.
In some places, it carries public recognition. In others, it blends into the fabric of everyday life.
But in this particular story, in the life of David B. Katague, it represents something universal:
The dignity of doing one’s job well. The quiet honor of contributing to something larger than oneself. The unseen legacy of care.
There is a kind of poetry in that. Not the poetry of grand speeches or celebrated achievements, but the poetry of consistency. Of showing up, day after day, and doing work that matters.
As I write this, I cannot help but think of the many individuals I have encountered in my own life, colleagues, professionals, public servants whose names will never be widely known, yet whose impact is immeasurable.
Perhaps that is the real story worth telling. Not just of David B. Katague, but of all those who live lives of quiet consequence.
In a world that often asks, “Who is famous?” Maybe we should ask instead,
“Who is faithful?” Because long after the headlines fade, it is the faithful who have been holding the world together all along.
Meanwhile, here's the AI Overview:
There is a real record of David B. Katague connected to the U.S. Food and Drug Administration (FDA), but he is not a public-facing or widely profiled official like an FDA commissioner or political appointee. Instead, he appears to have been a career scientist within the agency, working behind the scenes in drug evaluation.
๐งช His Role at the FDA
Based on official FDA documents:
- David B. Katague, Ph.D.
- Served as a Chemistry Team Leader
- Worked in the Center for Drug Evaluation and Research (CDER)
- Specifically in the Division of Anti-Infective Drug Products
His name appears on multiple FDA approval letters and regulatory documents in the late 1990s–early 2000s, where he:
- Reviewed new drug applications (NDAs)
- Oversaw chemistry and manufacturing quality
- Signed off on approvals for drugs like antibiotics (e.g., Augmentin)
This places him in a key scientific gatekeeping role, ensuring medications met FDA standards for safety, quality, and consistency before reaching the public.
๐งฌ What His Job Actually Meant
As a Chemistry Team Leader, his responsibilities likely included:
- Evaluating drug composition and stability
- Reviewing manufacturing processes
- Leading teams of FDA chemists
- Advising on whether a drug should be approved, modified, or rejected
This is highly technical, rigorous work, not visible to the public, but absolutely essential to modern medicine.
๐ Career Context
- Active in FDA records roughly 1990s to early 2000s
- Part of the internal scientific workforce rather than leadership
- His signature on documents indicates senior-level responsibility, not entry-level work
Some secondary sources suggest:
- Background in pharmaceutical chemistry
- Prior work in private industry before joining the FDA
- Filipino-American heritage (consistent with the Katague name’s origins)
๐ Why He Matters (Even If He’s Not Famous)
People like David B. Katague represent a category that rarely gets attention:
The career scientists who quietly determine whether drugs are safe enough for millions of people.
Every FDA-approved medication passes through individuals like him. While names like
David A. Kessler become publicly known, the scientific backbone of the FDA is made up of professionals like Katague.
✍️ Reflection
There’s something quietly powerful about a name that doesn’t make headlines.
David B. Katague’s story, what little we can see of it, is not one of spotlight or speeches, but of signatures at the bottom of documents that changed lives. Antibiotics approved. Treatments validated. Standards upheld.
No applause. No recognition. Just trust. And perhaps that is the deeper thread connecting the Katague name across continents from Iloilo, Negros Occidental, Philippines to America, to Australia, New Zealand, UK and beyond:
Not always visible. But always present. Doing the work that matters.
Finally, my Photo of the Day: Surface of the Moon taken by Artemis II Crew




